Patterns, Variants, Artifacts, and Pitfalls in Conventional Radionuclide Bone Imaging and SPECT/CT

Seminars in Nuclear Medicine

Volumn 39, Issue 6, 2009, Pages 380-395

  Gnanasegaran, Gopinath ^a   Cook, Gary ^b   Adamson, Kathryn ^a   Fogelman, Ignac ^a  

^a ST THOMAS HOSPITAL   (United Kingdom)

^b INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CONTRAST MEDIUM; MEDRONATE TECHNETIUM TC 99M; METAL; TRACER;

ABDOMEN; ARTIFACT; BLOOD FLOW; BONE METASTASIS; BONE SCINTISCANNING; BREAST PROSTHESIS; BREATHING; CENTRAL VENOUS CATHETER; COMPUTED TOMOGRAPHY SCANNER; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONTAMINATION; DRUG ACCUMULATION; DRUG EXCRETION; DRUG EXTRAVASATION; DRUG UPTAKE; FOREIGN BODY; HEAD; HUMAN; INJECTION SITE; INSTRUMENTATION; JEWELRY; KNEE; LONG BONE; MOTION; NECK; NOISE; OSTEOARTHROPATHY; OSTEOBLAST; PACEMAKER; PATIENT; PELVIS; PROSTHESIS; RADIATION; REVIEW; SALIVARY GLAND; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STOMACH; THORAX; THYROID GLAND; URINE; VERTEBRA;

ANIMALS; ARTIFACTS; BONE AND BONES; HUMANS; RADIOACTIVE TRACERS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TOMOGRAPHY, X-RAY COMPUTED;

EID: 70349433638     PISSN: 00012998     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.semnuclmed.2009.07.003     Document Type: Review

References (106)

1. Gnanasegaran G., Cook G.J., and Fogelman I. Musculoskeletal system. In: Biersack H.J., and Freeman L.M. (Eds). Nuclear Medicine Concise (2007), Springer, New York
2. O'Connor M.K., Brown M.L., Hung J.C., et al. The art of bone scintigraphy: Technical aspects. J Nucl Med 32 (1991) 2332-2341
3. Storey G., and Murray I.P.C. Bone scintigraphy: The procedure and interpretation. In: Ell P.J., and Gambhir S.S. (Eds). Nuclear Medicine in Clinical Diagnosis and Treatment Vol I (2004), Elsevier, Churchill Livingstone 593-622 New York
4. Cook G.J., and Fogelman I. The role of nuclear medicine in monitoring treatment in skeletal malignancy. Semin Nucl Med 31 (2001) 206-211
5. Cook G.J., and Fogelman I. Skeletal metastases from breast cancer: Imaging with nuclear medicine. Semin Nucl Med 29 (1999) 69-79
6. O'Sullivan J.M., and Cook G.J. A review of the efficacy of bone scanning in prostate and breast cancer. Q J Nucl Med 46 (2002) 152-159
7. Love C., Din A.S., Tomas M.B., et al. Radionuclide bone imaging: An illustrative review. Radiographics 23 (2003) 341-358
8. Baxter A.D., Coakley F.V., Finlay D.B., et al. The aetiology of solitary hot spots in the ribs on planar bone scans. Nucl Med Commun 16 (1995) 834-837
9. Tumeh S.S., Beadle G., and Kaplan W.D. Clinical significance of solitary rib lesions in patients with extraskeletal malignancy. J Nucl Med 26 (1985) 1140-1143
10. Tofe A.J., Francis M.D., and Harvey W.J. Correlation of neoplasms with incidence and localisation of skeletal metastases. An analysis of 1355 diphosphonate bone scans. J Nucl Med 16 (1975) 986-989
11. Gates G.F., and Dore E.K. Detection of craniosynostosis by bone scanning. Radiology 115 (1975) 665-671
12. Paterson D.C. Myositis ossificans circumscripta: Report of four cases without history of injury. Bone Joint Surg J Br 52 (1970) 296-301
13. Harbert J., and Desai R. Small calvarial bone scan foci-Normal variations. J Nucl Med 26 (1985) 1144-1148
14. Senda K., and Itoh S. Evaluation of diffusely high uptake by the Calvaria in bone scintigraphy. Ann Nucl Med 1 (1987) 23-26
15. Rao B.K., and Lieberman L.M. Parietal thinning: A cause for photopenia on bone scan. Clin Nucl Med 5 (1980) 313
16. Fink-Bennett D.M., and Shapiro E.E. The Angle of Louis. A potential pitfall ("Louie's Hot Spot") in bone scan interpretation. Clin Nucl Med 9 (1984) 352-354
17. Fogelman I., and Maisey M. An Atlas of Clinical Nuclear Medicine. (ed 1) (1988), Dunitz Ltd, London
18. Kwai A.H., Stomper P.C., and Kaplan W.D. Clinical significance of isolated scintigraphic sternal lesions in patients with breast cancer. J Nucl Med 29 (1988) 324-328
19. McCormick W.F.S. Foramena in man. Am J Forensic Med Pathol 2 (1981) 249-252
20. Delpassand E.S., Garcia J.R., Bhadkamkar V., et al. Value of SPECT imaging of the thoracolumbar spine in cancer patients. Clin Nucl Med 20 (1995) 1047-1051
21. Bushnell D.L., Kahn D., Huston B., et al. Utility of SPECT imaging for determination of vertebral metastases in patients with known primary tumors. Skeletal Radiol 24 (1995) 13-16
22. Han L.J., Au-Yong T.K., Tong W.C.M., et al. Comparison of bone SPECT and planar imaging in the detection of vertebral metastases in patients with back pain. Eur J Nucl Med 25 (1998) 635-638
23. Coakley F.V., Jones A.R., Finlay D.B., et al. The aetiology and distinguishing features of solitary spinal hot spots on planar bone scans. Clin Radiol 50 (1995) 327-330
24. Fogelman I., McKillop J.H., and Gray H.W. The "hot patella" sign: Is it of any clinical significance?. Concise communication. J Nucl Med 24 (1983) 312-315
25. Kipper M.S., Alazraki N.P., and Feiglin D.H. The "hot" patella. Clin Nucl Med 7 (1982) 28-32
26. D'Sa S., Abildgaard N., Tighe J., et al. Guidelines for the use of imaging in the management of myeloma. Br J Haematol 137 (2007) 49-63
27. Johns W.D., Garrick M.B., and Kaplan W.D. Leuprolide therapy for prostate cancer. An association with scintigraphic flare on bone scan. Clin Nucl Med 15 (1990) 485-487
28. Haywood J.L., Carbone P.P., Heuson J.C., et al. Assessment of response to therapy in advanced breast cancer. Eur J Cancer 13 (1977) 89-94
29. Citrin D.L. Problems and limitations of bone scanning with Tc99m phosphates. Clin Radiol 28 (1977) 97-105
30. Schneider J.A., Divgi C.R., Scott A.M., et al. Flare on bone scintigraphy following Taxol chemotherapy for metastatic breast cancer. J Nucl Med 35 (1994) 1748-1752
31. Loutfi I., Collier B.D., and Mohammed A.M. Nonosseous abnormalities on bone scans. J Nucl Med Technol 31 (2003) 149-153
32. Kaye J., and Hayward M. Soft tissue uptake on 99mTc methylene diphosphonate bone scan imaging: Pictorial review. Australas Radiol 46 (2002) 13-21
33. Gentili A., Miron S.D., and Bellon E.M. Nonosseous accumulation of bone-seeking radiopharmaceuticals. Radiographics 10 (1990) 871-881
34. Gentili A., Miron S.D., and Adler L.P. Review of some common artifacts in nuclear medicine. Clin Nucl Med 19 (1994) 138-143
35. McAfee J.C., Singh A., Roskopf M., et al. Experimental drug-induced changes in renal function and biodistribution of Tc99m MDP. Invest Radiol 18 (1983) 470-478
36. Hung J.C., Ponto J.A., and Hammes R.J. Radiopharmaceutical-related pitfalls and artifacts. Semin Nucl Med 26 (1996) 208-255
37. Wilson M.A., and Pollack M.J. Gastric visualization and image quality in radionuclide bone scanning: Concise communication. J Nucl Med 22 (1981) 518-521
38. Chaudhuri T.K. The effect of aluminum and pH on altered body distribution of Tc99m EHDP. Int J Nucl Med Biol 3 (1976) 37
39. Al-Enizi E., Kazem N., Owunwanne A., et al. Dextrose solutions yield radiopharmaceutical impurities: The "sweet" scans. J Nucl Med Technol 31 (2003) 33-36
40. Kessler J.R., Wells R.G., and Sty J.R. Skeletal scintigraphy: Radiographic artifacts. Clin Nucl Med 17 (1992) 511-512
41. Dogan A., and Rezai K. Incidental lymph node visualisation on bone scan due to subcutaneous infiltration of Tc99m MDP. Clin Nucl Med 18 (1993) 208-209
42. O'Connor M.K., and Kelly B.J. Evaluation of techniques for the elimination of Hot" bladder artifacts in SPECT of the pelvis. J Nucl Med 31 (1990) 1872-1875
43. Bunker S.R., Handmaker H., Torre D.M., et al. Pixel overflow artifacts in SPECT evaluation of the skeleton. Radiology 174 (1990) 229-232
44. Ogawa K. Image distortion and correction in single photon emission CT. Ann Nucl Med 18 (2004) 171-185
45. O'Connor M.K. Instrument- and computer-related problems and artifacts in nuclear medicine. Semin Nucl Med 26 (1996) 256-277
46. Forstrom L.A., Dunn W.L., O'Connor M.K., et al. Technical pitfalls in image acquisition, processing, and display. Semin Nucl Med 26 (1996) 278-294
47. Howarth D.M., Forstrom L.A., O'Connor M.K., et al. Patient-related pitfalls and artifacts in nuclear medicine imaging. Semin Nucl Med 26 (1996) 295-307
48. Kalendar W.A. Computed Tomography. (ed 2) (2005), Publicis Corporate Publishing, Erlangen, Germany
49. Popilock R., Sandrasagaren K., Harris L., et al. Artifact recognition for the nuclear technologist. J Nucl Med Technol 36 (2008) 79-81
50. Barrett J.F., and Keat N. Artefacts in CT: Recognition and avoidance. Radiographics 24 (2004) 1679-1691
51. Wilting J.E., and Timmer J. Artefacts in spiral-CT images and their relation to pitch and subject morphology. Eur Radiol 9 (1999) 316-322
52. Fleischmann D., Rubin G.D., Paik D.S., et al. Stair-step artifacts with single versus multiple detector-row helical CT. Radiology 216 (2000) 185-196
53. Silver M.D., Taguchi K., Hein I.A., et al. Windmill artefact in multislice CT. Proc SPIE 5032 (2003) 1918-1927
54. Zimmer A.M., Isitman A.T., and Holmes R.A. Enzymatic inhibition of diphosphonate: A proposed mechanism of tissue uptake. J Nucl Med 16 (1975) 352-356
55. Peller P., Ho V., and Kransdorf M. Extraosseous Tc99m MDP uptake: A pathophysiological approach. Radiographics 13 (1993) 715-734
56. Duong R., Volarich D., Fernandez-Ulloa M., et al. Tc99m MDP bone scan artefact: Abdominal soft tissue uptake secondary to subcutaneous heparin injection. Clin Nucl Med 9 (1984) 47
57. Nizami M.A., Gerntholtz T., and Swanepoel C.R. The role of bone scanning in the detection of metastatic calcification: A case report. Clin Nucl Med 25 (2000) 407-409
58. Low R.D., Hicks R.J., Gill G., et al. Tc99m MDP uptake in a cerebral infarct. Clin Nucl Med 17 (1992) 968-970
59. Padhy A.K., Gopinath P.G., and Amini A.C. Myocardial, pulmonary, diaphragmatic, gastric, splenic, and renal uptake oft c-99m MDP in patients with persistent, severe hypercalcemia. Clin Nucleus Med 15 (1990) 648-649
60. Coolens J., Devos P., and De Roo M. Diffuse pulmonary uptake of Tc99m bone imaging agents: Case report and survey. Eur J Nucl Med 11 (1985) 36-42
61. Maloof J., Hurst J., and Gupta N. Diffuse pulmonary uptake of Tc99m MDP in sarcoidosis. Clin Nucl Med 21 (1996) 77-79
62. Siegel M.E., Walker Jr. W.J., and Campbell J.L. Accumulation of 99mTc-diphosphonate in malignant pleural effusions. J Nucl Med 16 (1975) 883-885
63. Vanhecke W., Merckx E., De Roo M., et al. Soft tissue uptake on Tc99m MDP bone scan after cardioversion. Clin Nucl Med 14 (1989) 923
64. Lee V.W., Caldarone A.G., Falk R.H., et al. Amyloidosis of heart and liver: Comparison of Tc99m pyrophosphate and Tc99m methylene diphosphonate for detection. Radiology 148 (1983) 239-242
65. Atkins H.L., and Oster Z.H. Myocardial uptake of a bone tracer associated with hypercalcemia. Clin Nucl Med 9 (1984) 613-615
66. Ali A., Turner D.A., Rosenbush S.W., et al. Bone scintigram in cardiac amyloidosis: A case report. Clin Nucl Med 6 (1981) 105-108
67. Piccolo S., Lastoria S., Mainolfi C., et al. Technetium-99m-methylene diphosphonate scintimammography to image primary breast cancer. J Nucl Med 36 (1995) 718-724
68. Swayne L.C. Bone imaging in unusually massive breast carcinoma with chest wall invasion. Clin Nucl Med 16 (1991) 593-594
69. Harvey J.A., Fondriest J.E., and Smith M.M. Densely calcified breast mass. Invest Radiol 29 (1994) 516-518
70. Vieras F., and Boyd C.M. Diagnostic value of renal imaging incidental to bone scintigraphy with Tc99m phosphate compounds. J Nucl Med 16 (1975) 1109-1114
71. Biello D.R., Coleman R.E., and Stanley R.J. Correlation of renal images on bone scan and intravenous pyelogram. AJR Am J Roentgenol 127 (1976) 633-636
72. Wulfeck D.W., Sakow N.K., and Senler S. Detection of recurrent renal cell carcinoma by three-phase bone scan. Clin Nucl Med 18 (1993) 441-443
73. Bernard M., Hayward M., and Hayward C. Evaluation of intense renal parenchymal activity ("Hot Kidneys") on bone scintigraphy. Clin Nucl Med 15 (1990) 254-256
74. Gentili A., Miron S.D., Adler L.P., et al. Incidental detection of urinary tract abnormalities with skeletal scintigraphy. Radiographics 11 (1991) 571-579
75. Straub W.H., and Slasky B.S. Accumulation of bone scanning agent in a communicating renal cortical cyst. Clin Nucl Med 7 (1982) 378
76. Kim S.E., Kim D.Y., Lee D.S., et al. Absent or faint renal uptake on bone scan. Etiology and significance in metastatic bone disease. Clin Nucl Med 16 (1991) 545-549
77. Buxton-Thomas M.S., and Wraight E.P. High renal activity on bone scintigrams: A sign of hypercalcaemia?. Br J Radiol 56 (1983) 911-914
78. Koizumi K., Tonami N., and Hisada K. Diffusely increased Tc99m-MDP uptake in both kidneys. Clin Nucl Med 6 (1981) 362-365
79. Lutrin C.L., and Goris M.L. Pyrophosphate retention by previously irradiated renal tissue. Radiology 133 (1979) 207-209
80. Trackler R.T., and Chinn R.Y.W. Amphotericin B therapy: A cause of increased renal uptake of Tc99m MDP. Clin Nuci Med 7 (1982) 293
81. Sugimura K., Narabayashi I., Yamazaki K., et al. Bone scintigraphic findings in 2 cases of myositis ossificans progressiva. [Kaku Igaku Japanese]. J Nucl Med 20 (1983) 875-879
82. Chew F.S., Hudson T.M., and Enneking W.F. Radionuclide imaging of soft tissue neoplasms. Semin Nucl Med 11 (1981) 266-276
83. Maurer A., Paczolt E., and Myers A. Diagnosis of traumatic myositis intrinsic muscles of the hand by the use of three-phase skeletal scintigraphy. Clin Nucl Med 15 (1990) 535-538
84. Sud A., Wilson M., and Mountz J. Unusual clinical presentation and scintigraphic pattern in myositis ossificans. Clin Nucl Med 17 (1991) 198-199
85. Abdel-Dayem H. Tc99m-MDP uptake in rhabdomyolysis. Clin Nucl Med 6 (1981) 130
86. Buchpiguel C.A., Roizemblatt S., Pastor E.H., et al. Cardiac and skeletal muscle scintigraphy in dermato- and polymyositis: Clinical implications. Eur J Nucl Med 23 (1996) 199-203
87. Pape H.C., Lehmann U., van Griensven M., et al. Heterotopic ossifications in patients after severe blunt trauma with and without head trauma: Incidence and patterns of distribution. J Orthop Trauma 15 (2001) 229-237
88. Lafforgue P., Siles S., Daumen-Legre V., et al. An unexpected, benign cause of increased muscular uptake at bone scintigraphy. Clin Exp Rheumatol 12 (1994) 309-311
89. Romyn A.M., Bushnell D.L., Freeman M.L., et al. Visualization of metastatic liver disease on technetium-99m bone scintigraphy. Clin Nucl Med 12 (1987) 264-267
90. Sherkow L., Ryo U., Fabich D., et al. Visualisation of the liver, gallbladder and intestine on bone scintigraphy. Clin Nucl Med 9 (1984) 440-443
91. Adalet I., Kocak M., Oguz H., et al. Incidental visualisation of hepatic hemangiomas during Tc99m (v) DMSA, Tl-201 and Tc99m MDP imaging. Clin Nucl Med 20 (1995) 1106-1107
92. Connolly L.P., Bloom D.A., Kozakewich H., et al. Localization of Tc99m MDP in neuroblastoma metastases to the liver and lung. Clin Nucl Med 21 (1996) 629-633
93. Silberstein E.B., DeLong S., and Cline J. Tc99m diphosphonate and sulfur colloid uptake by the spleen in sickle cell disease: Interrelationship and clinical correlates. J Nucl Med 25 (1984) 1300-1303
94. Hansen S., and Stadalnik R.C. Liver uptake of 99mTc-pyrophosphate. Semin Nucl Med 12 (1982) 89-91
95. Morrison S.C., and Adler L.P. Bone imaging agent uptake with hepatoblastoma. Clin Nucl Med 17 (1992) 680
96. Solanki H.P., and Chertow B.S. Dramatic improvement of soft tissue uptake of liver metastases on bone imaging. Clin Nucl Med 19 (1994) 346-347
97. Dhekne R.D. Splenic concentration of bone imaging agents in functional asplenia. Clin Nucl Med 6 (1981) 313-317
98. Dravid V.S., and Heyman S. Splenic uptake on bone scanning in autoimmune hemolytic anemia. Clin Nucl Med 15 (1990) 584
99. Meyer M., and McClaughry P. Reversible Tc99m diphosphonate uptake in gastric tissue associated with malignancy related hypercalcemia. Clin Nucl Med 20 (1995) 767-769
100. Duong R., Volarich D., Fernandez-Ulloa M., et al. Tc99m MDP bone scan artefact: Abdominal soft tissue uptake secondary to subcutaneous heparin injection. Clin Nucl Med 9 (1984) 47
101. Gordon L., Schabel S.I., Holland R.D., et al. Technetium-99m methylene diphosphonate accumulation in ascitic fluid due to neoplasm. Radiology 139 (1981) 699-702
102. Choy D., and Murray I.P. Metastatic visceral calcification identified by bone scanning. Skeletal Radiol 5 (1980) 151-159
103. Yang K.T., and Lin T.S. Visualization of a supradiaphragmatic stomach in a patient with esophagogastrectomy who practiced urine therapy during bone scan. Clin Nucl Med 26 (2001) 1042
104. Kosuda S., Katagiri S., Ka W.J., et al. Demonstration of the ascending colon on Tc99m MDP skeletal imaging: Pitfall in bone scanning by a faith cure of drinking urine. Clin Nucl Med 25 (2000) 1040-1041
105. Adams K.J., Shuler S.E., Witherspoon L.R., et al. A retrospective analysis of renal abnormalities detected on bone scans. Clin Nucl Med 5 (1980) 1-7
106. Reddy P.S., and Merrick M.V. Skeletal scintigraphy in carcinoma of the kidney. Br J Urol 55 (1983) 171-173